Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

NewLimit

Biotech & Life Sciences · South San Francisco, United States · Founded 2021 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Headcount
<100
Current team size
Unlock exact value

Investors

23 investors on NewLimit's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 7 investors entered at this stage
Founders Fund
Dimension
Kleiner Perkins
Fred Ehrsam
Eric Schmidt
Garry Tan
Elad Gil
Series B+ 16 investors entered at this stage
John Collison
Daniel Gross
Patrick Collison
Nat Friedman
Khosla Ventures
Section 32
Eli Lilly
Human Capital
Boost VC
Joe Lonsdale
Duke Management Company
Dimension
Valor Equity Partners
Joshua Kushner
Brian Armstrong
Abstract Ventures

Global footprint

Where NewLimit has talent and traffic

Web traffic by country
21K monthly visits
across markets
🇿🇦 South Africa58.6%
🇺🇸 United States37.1%
🇫🇷 France4.3%
🇮🇳 India0.5%
Top 4 markets shown

See NewLimit on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo